The F.D.A. is expected to soon authorize Pfizer-BioNTech’s booster for 5- to 11-year-olds.. Coronavirus (2019-nCoV), Vaccination and Immunization, Clinical Trials, Pfizer Inc, BioNTech SE, Food and Drug Administration, United States